Literature DB >> 17476548

Levels of lipid peroxidation in human plasma and erythrocytes: comparison between fatty acids and cholesterol.

Yasukazu Yoshida1, Yoshiro Saito, Mieko Hayakawa, Yoko Habuchi, Yasuharu Imai, Yoshiyuki Sawai, Etsuo Niki.   

Abstract

Lipid peroxidation has gained renewed attention with increasing evidence showing its biological role in producing toxic compounds and cellular signaling mediators. The assessment of lipid peroxidation levels in vivo is difficult partly because lipids are oxidized by different oxidants by different mechanisms to give versatile types of products, which may undergo metabolism and secondary reactions. In the present study, total hydroxyoctadecadienoic acids (tHODE) and 7alpha- and 7beta-hydroxycholesterol (t7-OHCh) from 44 healthy human subjects were assessed as biomarkers after reduction with sodium borohydride followed by saponification with potassium hydroxide comparing with the prevailing standard 8-isoprostaglandin F(2alpha) (t8-iso-PGF(2alpha)). The average concentrations of tHODE, total 8-isoprostaglandin F(2alpha) (t8-iso-PGF(2alpha)), t7alpha-OHCh, and t7beta-OHCh were 203, 0.727, 87.1, and 156 nmol/l plasma and 1,917, 12.8, 1,372, and 3,854 nmol/l packed erythrocytes, respectively. The ratios of tHODE and t7-OHCh to the parent substrates were 194 and 3,519 micromol tHODE/mol linoleates and 40.9 and 686 micromol t7-OHCh/mol cholesterol in plasma and erythrocytes, respectively. It was found that (1) t7-OHCh in blood was unexpectedly high, as high as or even higher than tHODE, (2) the amounts of tHODE was more than 100 fold higher than t8-iso-PGF(2alpha) (3) the level of lipid oxidation products in erythrocytes was higher than that in plasma, and (4) lipid peroxidation products level tended to increase while antioxidant level decrease with age. These products may be used as potential biomarker for assessment of lipid peroxidation and oxidative stress in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476548     DOI: 10.1007/s11745-007-3037-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  39 in total

1.  Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study.

Authors:  Cestmír Zita; Kim Overvad; Svend Aage Mortensen; Christian Dan Sindberg; Sven Moesgaard; Douglas A Hunter
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

2.  Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.

Authors:  M B Kadiiska; B C Gladen; D D Baird; L B Graham; C E Parker; B N Ames; S Basu; G A Fitzgerald; J A Lawson; L J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; M K Shigenaga; J Sun; P B Walter; K B Tomer; J C Barrett; R P Mason
Journal:  Free Radic Biol Med       Date:  2005-03-15       Impact factor: 7.376

3.  In vivo action of 15-lipoxygenase in early stages of human atherogenesis.

Authors:  H Kühn; D Heydeck; I Hugou; C Gniwotta
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Oxidative status of human low density lipoprotein isolated by anion-exchange high-performance liquid chromatography--assessment by total hydroxyoctadecadienoic acid, 7-hydroxycholesterol, and 8-iso-prostaglandin F(2alpha).

Authors:  Soichi Kitano; Yasukazu Yoshida; Katsumi Kawano; Nozomu Hibi; Etsuo Niki
Journal:  Anal Chim Acta       Date:  2006-12-23       Impact factor: 6.558

5.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Authors:  J D Morrow; K E Hill; R F Burk; T M Nammour; K F Badr; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 6.  Lipid peroxidation: mechanisms, inhibition, and biological effects.

Authors:  Etsuo Niki; Yasukazu Yoshida; Yoshiro Saito; Noriko Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2005-08-19       Impact factor: 3.575

7.  Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3.

Authors:  Ling Gao; Jiakun Wang; Konjeti R Sekhar; Huiyong Yin; Nicholas F Yared; Scott N Schneider; Soumya Sasi; Timothy P Dalton; Mark E Anderson; Jefferson Y Chan; Jason D Morrow; Michael L Freeman
Journal:  J Biol Chem       Date:  2006-11-25       Impact factor: 5.157

8.  Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.

Authors:  M Hult; B Elleby; N Shafqat; S Svensson; A Rane; H Jörnvall; L Abrahmsen; U Oppermann
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

9.  Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults.

Authors:  Michael V Miles; Paul S Horn; John A Morrison; Peter H Tang; Ton DeGrauw; Amadeo J Pesce
Journal:  Clin Chim Acta       Date:  2003-06       Impact factor: 3.786

10.  Significance of biological parameters of human blood levels of CoQ10.

Authors:  J Komorowski; K Muratsu; Y Nara; R Willis; K Folkers
Journal:  Biofactors       Date:  1988-01       Impact factor: 6.113

View more
  8 in total

Review 1.  Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2016-11-10       Impact factor: 4.013

2.  Trien conjugates, schiff bases, and ceruloplasmin concentrations as markers of the onset of the risk of autodermoplasty complications.

Authors:  Y I Yarets; I A Novikova; L N Rubanov
Journal:  Ann Burns Fire Disasters       Date:  2009-12-31

3.  Inhibition of serum cholesterol oxidation by dietary vitamin C and selenium intake in high fat fed rats.

Authors:  M Menéndez-Carreño; D Ansorena; F I Milagro; J Campión; J A Martínez; I Astiasarán
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

4.  Multi-Biomarkers for Early Detection of Type 2 Diabetes, Including 10- and 12-(Z,E)-Hydroxyoctadecadienoic Acids, Insulin, Leptin, and Adiponectin.

Authors:  Aya Umeno; Kohzoh Yoshino; Yoshiko Hashimoto; Mototada Shichiri; Masatoshi Kataoka; Yasukazu Yoshida
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

5.  DHA concentration of red blood cells is inversely associated with markers of lipid peroxidation in men taking DHA supplement.

Authors:  Mototada Shichiri; Yuriko Adkins; Noriko Ishida; Aya Umeno; Yasushi Shigeri; Yasukazu Yoshida; Dawn M Fedor; Bruce E Mackey; Darshan S Kelley
Journal:  J Clin Biochem Nutr       Date:  2014-09-09       Impact factor: 3.114

6.  Role of Membrane Lipids in the Regulation of Erythrocytic Oxygen-Transport Function in Cardiovascular Diseases.

Authors:  Victor V Revin; Natalia V Gromova; Elvira S Revina; Maria I Martynova; Angelina I Seikina; Nadezhda V Revina; Oksana G Imarova; Ilia N Solomadin; Alexander Yu Tychkov; Nikolai Zhelev
Journal:  Biomed Res Int       Date:  2016-10-30       Impact factor: 3.411

7.  Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo.

Authors:  Yasukazu Yoshida; Aya Umeno; Mototada Shichiri
Journal:  J Clin Biochem Nutr       Date:  2012-12-06       Impact factor: 3.114

8.  Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes.

Authors:  Aya Umeno; Mototada Shichiri; Noriko Ishida; Yoshiko Hashimoto; Kaori Abe; Masatoshi Kataoka; Kohzoh Yoshino; Yoshihisa Hagihara; Nanako Aki; Makoto Funaki; Yasuhiko Asada; Yasukazu Yoshida
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.